Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when INSP files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsInspire Medical announces retirement of 18-year board member Casey Tansey
Filed July 22, 2026 · Period ending July 16, 2026 · ~1 min read
Key Changes
-
medium
Casey Tansey retiring from Board effective July 30, 2026, after 18+ years of service; represented U.S. Venture Partners and led Series A financing in 2007.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
low
Retirement is amicable with no disagreement regarding company operations, policies, or practices; replacement director to be announced.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
Summary
Inspire Medical disclosed the planned retirement of Casey Tansey from its Board of Directors, effective July 30, 2026. Tansey has served on the Board for over eighteen years, joining in November 2007 when he represented U.S. Venture Partners and led the company's Series A financing round. The filing explicitly states his departure is not due to any disagreement with the company.
This is a routine governance matter reflecting natural board turnover after a long tenure. The company indicated it will announce a replacement director in the near future. For a retail holder, the departure of a long-serving director who was present through the company's early financing and growth represents normal board evolution, with no immediate operational or strategic implications.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Board member Casey Tansey retiring July 30, 2026, will not stand for re-election at 2027 annual meeting; no disagreement with company.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
On July 16, 2026, Casey Tansey, a member of the Board of Directors (the “Board”) of Inspire Medical Systems, Inc. (the “Company”), notified the Company of his decision to retire from the Board (and the committees on which he serves) and not stand for re-election at the Company’s 2027 Annual Meeting of Stockholders (the “2027 Annual Meeting”). Mr. Tansey’s retirement will become effective July 30, 2026.
Casey Tansey, a current board member, is retiring from the Board and all committees effective July 30, 2026, and will not stand for re-election at the 2027 annual meeting. This is a planned retirement with no indication of disagreement or conflict.
Added in current filing · verify on EDGAR →
Mr. Tansey’s decision to retire and not stand for re-election was not the result of any disagreement with the Company or any matter relating to the Company’s operation, policies or practices.
The filing explicitly states that Mr. Tansey's retirement was not due to any disagreement with the company regarding operations, policies, or practices. This is a standard disclosure confirming the departure is amicable and routine.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the retirement of Casey M. Tansey from the Inspire Board after more than eighteen years of service, effective July 30.
Casey M. Tansey is retiring from Inspire's Board of Directors effective July 30, 2026, after serving for more than eighteen years. Tansey represented U.S. Venture Partners and led Inspire's Series A financing in November 2007, serving on the Board since that time. The company plans to announce a replacement director in the near future.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 23, 2026 · How we verify